Showing results (201-210 of 235) with videos related to
Sort By:
Pageof 24
Diabetes, Obesity & Metabolism|January 9, 2025
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetesAleksander L Hansen, Mette K Andersen, Leonie M Engelhard, et al.BMC Endocrine Disorders|August 29, 2014
Lifestyle and clinical factors associated with elevated C-reactive protein among newly diagnosed Type 2 diabetes mellitus patients: a cross-sectional study from the nationwide DD2 cohortElisabeth Svensson, Anil Mor, Jørgen Rungby, et al.Neurology|June 4, 2024
Lipid Levels and Risk of Diabetic Polyneuropathy in 2 Danish Type 2 Diabetes CohortsFrederik P B Kristensen, Diana H Christensen, Brian C Callaghan, et al.Elife|October 16, 2014
Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic targetZhiping Yang, Yuh-Chin T Huang, Henry Koziel, et al.BMJ (Clinical Research Ed.)|December 17, 2021
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort studyAnders Husby, Jørgen Vinsløv Hansen, Emil Fosbøl, et al.Diabetes/Metabolism Research and Reviews|November 25, 2017
Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 studyA Bo, R W Thomsen, J S Nielsen, et al.Open Forum Infectious Diseases|October 30, 2019
Influence of Acetylsalicylic Acid Use on Risk and Outcome of Community-Acquired <i>Staphylococcus aureus</i> Bacteremia: A Population-Based StudyJesper Smit, Michael Dalager-Pedersen, Kasper Adelborg, et al.Diabetes, Obesity & Metabolism|January 18, 2024
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohortsCristina Rebordosa, Reimar W Thomsen, Arlene K Tave, et al.Diabetologia|May 22, 2024
Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortalityAleksander L Hansen, Charlotte Brøns, Leonie M Engelhard, et al.Diabetes Care|October 1, 2020
Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort StudyFrederik P Kristensen, Diana H Christensen, Brian C Callaghan, et al.Pageof 24